[PDF] Top 20 Pathway construction of chronic inflammatory demyelinating polyneuropathy (CIPD): a neurodegenerative disease

... many inflammatory cells and MRI imaging of nerve root is done to look for any enlargement or signs of inflammation (Köller and Hubertus, ...this disease goes un-noticed. This rare disease affects any ... See full document

... of disease. This is also thought to be one of the major effector mechanisms in the treatment of CIDP. The anti-inflamma- tory activity of IVIg is at least partly mediated by its ability to prevent the formation of ... See full document

... s disease, and QuantiMedis, a clinical research organization providing Q-Motor (quantitative motor) services in clinical trials and ...of Neurodegenerative Diseases and Hertie-Institute for Clinical Brain ... See full document

... of disease processes have been proposed as dis- cussed ...of inflammatory demyelination due to peripheral immune system activation (the outside-in ...of disease progres- sion suggests that ... See full document

... Results: UPSS was increased in six out of 13 patients. Nerve enlargement was mostly inhomogeneous and regional. The median, ulnar, and vagal nerves presented with more prominent alterations than nerves of the lower ... See full document

... tuberculosis, bacterial and fungal and his throat culture were also negative. Random and 24 hrs urinalysis test results were normal. The patient general condition was relatively improved during the hospitalization. Gait ... See full document

... Needle EMG also can provide information on the rate of axonal loss. In acute and ongoing processes (recent denervation), fibrillation potentials tend to be large in amplitude (>500 μV). They become smaller as the ... See full document

... The development of highly concentrated Ig prepara- tions and special pumps to administer larger volumes subcutaneously has also raised interest in this route of administration for patients with inflammatory ... See full document

... and disease controls than in healthy controls (p < ...to disease controls, SMA type 2 patients were significantly slower (p < ...3b/4, disease controls) and healthy controls (p > ... See full document

... of neurodegenerative nerve diseases have not been well ...of neurodegenerative diseases as well as some can- ...various neurodegenerative diseases as well as some cancers, and its promise as a ... See full document

... We used a panel of TCR V ␤ specific monoclonal antibodies on cryosections of sural nerve biopsy spec- imens from patients with CIDP or nonsystemic vas- culitic neuropathy, as well as from control patients with ... See full document

... mean disease duration, 5 months; range, 0 – 8 month; median Expanded Disability Status Scale [EDSS], 1; range, 0 – ...mean disease duration, 51 months; range, 3–189 months; median EDSS, ... See full document

... decrease inflammatory cell infil- tration, and we found Hughes scale score was significantly lower after treatment, this result suggested IVIG could suppress peripheral nerve injury and encourage neurofunc- tional ... See full document

... Case presentation: We describe an episode of Guillain-Barré syndrome presenting as acute inflammatory demyelinating polyneuropathy in a 30-year-old man testing positive for Immunodeficiency Virus, ... See full document

... Case presentation: We describe an episode of Guillain-Barré syndrome presenting as acute inflammatory demyelinating polyneuropathy in a 30-year-old man testing positive for Immunodeficiency Virus, ... See full document

... The model was also evaluated using dif- ferent assumptions about the utility gain from IVIG, the extrapolation of IVIG relapse rates, treatment switching for corticosteroid patients afte[r] ... See full document

... Methods: We retrospectively evaluated the medical records and electrodiagnostic study (EDS) of 121 GBS patients who were managed in our hospital during 11 years. After regarding the exclusion criteria, patients ... See full document

... A ship captain, 55 year old Caucasian male, presented with an 18 month history of symmetrical and progres- sive numbness and paresthesia in his feet, which over the last 6 months spread proximally and affected his hands ... See full document

... This case report is of a patient who is suffering from an unclear autoimmune demyelinating polyneuropathy with progressive weakness in upper limb with no sensory involvement. Her symptoms did not resolve ... See full document

... accompanying diabetes. Therefore, clinical reality suggests the need for the effective treatment of neuropathic pain accompanying diabetes. Diabetes mellitus represents a syndrome of complex metabolic diseases united by ... See full document